CorMedix Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
CRMD Nasdaq 2830 www.cormedix.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for CorMedix Inc.

Revolution Medicines Posts Wider-Than-Expected Loss in Q3, Sales Nil - Nov 6th, 2025 11:59 am
JAZZ Beats on Q3 Earnings & Sales, Narrows '25 Sales View - Nov 6th, 2025 8:50 am
Viatris Tops Q3 Earnings & Revenue Estimates, Ups '25 Guidance - Nov 6th, 2025 8:24 am
Amicus' Q3 Earnings Beat, Higher Product Sales Drive Y/Y Revenues - Nov 5th, 2025 8:08 am
Bet on 5 Top-Ranked Stocks With Rising P/E - Nov 5th, 2025 7:11 am
All You Need to Know About CorMedix (CRMD) Rating Upgrade to Strong Buy - Nov 4th, 2025 10:00 am
New Strong Buy Stocks for November 4th - Nov 4th, 2025 5:22 am
Could the FDA Approval Spark a New Chapter for CorMedix in 2025? - Nov 3rd, 2025 12:08 am
CorMedix Inc. to Report Third Quarter 2025 Financial Results and Provide a Corporate Update on November 12, 2025 - Oct 31st, 2025 6:30 am
CRMD vs. TBPH: Which Small-Cap Biotech Stock Is the Better Buy? - Oct 30th, 2025 12:05 pm
Amarin's Q3 Earnings Lag Estimates, Revenues Beat, Stock Down - Oct 30th, 2025 10:08 am
United Therapeutics Q3 Earnings Beat Estimates, Revenues Miss Mark - Oct 29th, 2025 9:24 am
RGEN'S Q3 Earnings Beat Estimates, Revenues Surge Y/Y, Stock Down - Oct 29th, 2025 9:18 am
Should Investors Buy CorMedix Stock Ahead of Q3 Earnings Report? - Oct 28th, 2025 8:40 am
Assessing CorMedix (CRMD) Valuation Following Recent Share Price Fluctuations - Oct 25th, 2025 4:12 am
CorMedix Inc. Receives Innovative Technology Designation From Vizient for DefenCath - Oct 23rd, 2025 6:30 am
SNY's Efdoralprin Alfa Meets Key Endpoints in Rare Disease Study - Oct 22nd, 2025 8:18 am
Earnings Estimates Rising for CorMedix (CRMD): Will It Gain? - Oct 21st, 2025 10:20 am
Wall Street Analysts See a 68.59% Upside in CorMedix (CRMD): Can the Stock Really Move This High? - Oct 21st, 2025 7:55 am
CorMedix (CRMD) Surges 19.5%: Is This an Indication of Further Gains? - Oct 21st, 2025 7:15 am